Federation des caisses Desjardins du Quebec’s Pacific Biosciences PACB Stock Holding History

Federation des caisses Desjardins du Quebec’s Portfolio PACB Stock Details PACB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$12.6K	Hold	7,500	–	–	﹤0.01%	2341
2026 Q1	$9.9K	Hold	7,500	–	–	﹤0.01%	2327
2025 Q4	$14K	Sell	7,500 -1,700	-18%	-$3.27K	﹤0.01%	2149
2025 Q3	$11.8K	Hold	9,200	–	–	﹤0.01%	2208
2025 Q2	$11.4K	Hold	9,200	–	–	﹤0.01%	1994
2025 Q1	$10.9K	Buy	9,200 +2,300	+33%	+$3.53K	﹤0.01%	1934
2024 Q4	$12.6K	Buy	6,900 +5,000	+263%	+$9.76K	﹤0.01%	1801
2024 Q3	$3.23K	Hold	1,900	–	–	﹤0.01%	2160
2024 Q2	$2.6K	Hold	1,900	–	–	﹤0.01%	2074
2024 Q1	$7.13K	Buy	1,900 +1,700	+850%	+$9.95K	﹤0.01%	1887
2023 Q4	$1.96K	Hold	200	–	–	﹤0.01%	2069
2023 Q3	$1.67K	Hold	200	–	–	﹤0.01%	2092
2023 Q2	$2.66K	Hold	200	–	–	﹤0.01%	2021
2023 Q1	$2.32K	Hold	200	–	–	﹤0.01%	2063
2022 Q4	$1.64K	Hold	200	–	–	﹤0.01%	2230
2022 Q3	$1.16K	Hold	200	–	–	﹤0.01%	2328
2022 Q2	$884	Hold	200	–	–	﹤0.01%	2398
2022 Q1	$1.82K	Hold	200	–	–	﹤0.01%	2374
2021 Q4	$4.09K	Hold	200	–	–	﹤0.01%	2240
2021 Q3	$5.11K	Hold	200	–	–	﹤0.01%	2227
2021 Q2	$6.99K	Sell	200 -750	-79%	-$21.8K	﹤0.01%	2151
2021 Q1	$31.6K	Buy	+950	New	+$33.3K	﹤0.01%	1683
2018 Q4	–	Sell	-700	Closed	-$3.79K	–	2128
2018 Q3	$3.79K	Hold	700	–	–	﹤0.01%	1933
2018 Q2	$2.48K	Hold	700	–	–	﹤0.01%	1996
2018 Q1	$1.44K	Hold	700	–	–	﹤0.01%	2027
2017 Q4	$1.85K	Hold	700	–	–	﹤0.01%	2005
2017 Q3	$3.67K	Hold	700	–	–	﹤0.01%	1884
2017 Q2	$2.49K	Buy	+700	New	+$2.82K	﹤0.01%	1991

Other funds holding PACB

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

SoftBank Group Tokyo, Japan $18.2B AUM 177.65% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Federation des caisses Desjardins du Quebec's PACB Position: Q2 2026 in Review

Federation des caisses Desjardins du Quebec held its Pacific Biosciences (PACB) position steady in Q2 2026 at 7,500 shares worth $12.6K. The position accounts for ﹤0.01% of the portfolio, ranked #2341.

Federation des caisses Desjardins du Quebec first reported a position in PACB in Q2 2017 and has held it in 28 quarters since. The position peaked at $31.6K in Q1 2021. 223 funds tracked by Wall St. Rank hold PACB as of Q2 2026.

Federation des caisses Desjardins du Quebec held 7,500 shares of Pacific Biosciences worth $12.6K as of Q2 2026.
Federation des caisses Desjardins du Quebec left its Pacific Biosciences share count unchanged in Q2 2026.
Pacific Biosciences made up ﹤0.01% of Federation des caisses Desjardins du Quebec's portfolio in Q2 2026, its #2341 holding.
Federation des caisses Desjardins du Quebec first reported a position in Pacific Biosciences in Q2 2017 and has held it in 28 quarters since.
Federation des caisses Desjardins du Quebec's Pacific Biosciences position peaked at $31.6K in Q1 2021.
223 funds tracked by Wall St. Rank held Pacific Biosciences as of Q2 2026.

Based on Federation des caisses Desjardins du Quebec's 13F filing for Q2 2026, filed 14 Aug 2026.